PR Newswire - End of Day
London, October 14
This is the END of day message for the PR Newswire Disclose service
The content and accuracy of all information published on the Disclose service is the responsibility of the originating company or organisation and not PR Newswire or distributing companies. These companies include (but are not limited to) Thomson Reuters, Bloomberg, and FE Investegate. However, PR Newswire shall use its reasonable efforts to correct any error or omission brought to its attention.
Neither PR Newswire nor its distributing companies who place the information onto their services accept any responsibility for any use made of the information provided on the Disclose service and they will not be liable for any loss suffered thereby. However nothing shall limit any party's liability for fraud, death or personal injury caused by its negligence.
All information contained in the Disclose service should be independently checked prior to any use or publication.
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- iQIYI releases 260 new titles at 2021 iJOY Conference, integrating content with technology
- St Kitts and Nevis Expands Visa-Free Travel to Palestine, Recording Fourth Diplomatic Agreement in Less Than Four Weeks
- EQS-News: Netcetera ACS ensuring secure payments with American Express Middle East
- Core One Labs Applauds the City of Seattle in Their Efforts to Decriminalize Psylocibin and Other Natural Occuring Entheogenic Drugs
- Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting
- Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab